InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by William Arsani, Director. Director active across 1 companies, notably Design Therapeutics, Inc.. Aggregated, 3 disclosures have been published. Total volume traded: €1.5m. The latest transaction was disclosed on 21 March 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations3 total
€429,84225,000 shares@ €17.19370.048% mcap29.1% of flow
Common Stock
SEC:0001209191-22-020638:0·
Ideal exit: 16 Dec 2022 (T+270)
€523,27340,000 shares@ €13.0818100.0% of flow
Common Stock
SEC:0001209191-21-054492·
Ideal exit: 28 May 2022 (T+270)
€523,27340,000 shares@ €13.08180.058% mcap35.4% of flow
Common Stock
SEC:0001209191-21-054492:0·
Ideal exit: 28 May 2022 (T+270)
3 of 3 declarations
About William Arsani
William Arsani is a Board Member at Design Therapeutics, Inc. In this role, he participates in overseeing the company's activities and making strategic decisions. William brings his expertise to guide the direction of Design Therapeutics and ensure compliance with governance standards. His commitment to operational excellence is a valuable asset to the board.
